Advertisement
Screener

CRYOPORT, INC. (CYRX) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

CRYOPORT, INC. Operating Expenses

CRYOPORT, INC. (CYRX) reported Operating Expenses of $32.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-06

  • CRYOPORT, INC. operating expenses for the quarter ending 2026-06-30 was $32.86M, a 5.92% increase year-over-year.
  • CRYOPORT, INC. operating expenses for the quarter ending 2026-03-31 was $31.53M, a 22.03% increase year-over-year.
  • CRYOPORT, INC. operating expenses for the quarter ending 2025-12-31 was $31.74M, a 1.54% decline year-over-year.
  • CRYOPORT, INC. operating expenses for the quarter ending 2025-09-30 was $31.26M, a 1.40% increase year-over-year.
  • CRYOPORT, INC. operating expenses for fiscal 2025 was $119.86M, a 37.35% decline from fiscal 2024.
  • CRYOPORT, INC. operating expenses for fiscal 2024 was $191.33M, a 8.79% increase from fiscal 2023.
  • CRYOPORT, INC. operating expenses for fiscal 2023 was $175.87M, a 29.53% increase from fiscal 2022.
  • CRYOPORT, INC. operating expenses for fiscal 2022 was $135.78M, a 18.68% increase from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-06-30$32.86M
10-Q · filed 2026-08-06
$64.39M
10-Q · filed 2026-08-06
$96.13M
derived: sum of 3 quarters · filed 2026-08-06
$127.39M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$31.53M
10-Q · filed 2026-05-05
$63.27M
derived: sum of 2 quarters · filed 2026-05-05
$94.53M
derived: sum of 3 quarters · filed 2026-05-05
$125.55M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$31.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$63.00M
derived: sum of 2 quarters · filed 2026-03-05
$94.03M
derived: sum of 3 quarters · filed 2026-08-06
$119.86M
10-K · filed 2026-03-05
2025-09-30$31.26M
10-Q · filed 2025-11-06
$62.28M
derived: sum of 2 quarters · filed 2026-08-06
$88.12M
10-Q · filed 2025-11-06
$120.36M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$31.03M
10-Q · filed 2026-08-06
$56.86M
10-Q · filed 2026-08-06
$89.10M
derived: sum of 3 quarters · filed 2026-08-06
$119.92M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$25.84M
10-Q · filed 2026-05-05
$28.13M
10-Q · filed 2025-05-08
$58.07M
derived: sum of 2 quarters · filed 2026-05-05
$88.90M
derived: sum of 3 quarters · filed 2026-05-05
$184.59M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$32.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$63.06M
derived: sum of 2 quarters · filed 2026-03-05
$158.75M
derived: sum of 3 quarters · filed 2026-03-05
$191.33M
10-K · filed 2026-03-05
$230.50M
10-K · filed 2025-03-07
2024-09-30$30.82M
10-Q · filed 2025-11-06
$41.81M
10-Q · filed 2024-11-07
$126.52M
derived: sum of 2 quarters · filed 2025-11-06
$159.09M
10-Q · filed 2025-11-06
$189.28M
10-Q · filed 2024-11-07
$213.60M
derived: sum of 4 quarters · filed 2026-03-05
2024-06-30$95.69M
10-Q · filed 2025-08-12
$104.42M
10-Q · filed 2024-08-08
$128.26M
10-Q · filed 2025-08-12
$147.47M
10-Q · filed 2024-08-08
$182.78M
derived: sum of 3 quarters · filed 2026-03-05
$223.95M
derived: sum of 4 quarters · filed 2026-03-05
2024-03-31$32.57M
10-Q · filed 2025-05-08
$43.06M
10-Q · filed 2024-05-08
$87.09M
derived: sum of 2 quarters · filed 2026-03-05
$128.26M
derived: sum of 3 quarters · filed 2026-03-05
$171.33M
derived: sum of 4 quarters · filed 2026-03-05
2023-12-31$54.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$95.69M
derived: sum of 2 quarters · filed 2026-03-05
$138.75M
derived: sum of 3 quarters · filed 2026-03-05
$175.87M
10-K · filed 2026-03-05
$214.49M
10-K · filed 2024-03-13
2023-09-30$41.17M
10-Q · filed 2024-11-07
$84.24M
derived: sum of 2 quarters · filed 2024-11-07
$121.36M
10-Q · filed 2024-11-07
$158.67M
derived: sum of 4 quarters · filed 2025-03-07
2023-06-30$43.06M
10-Q · filed 2024-08-08
$80.18M
10-Q · filed 2024-08-08
$117.49M
derived: sum of 3 quarters · filed 2025-03-07
$151.71M
derived: sum of 4 quarters · filed 2025-03-07
2023-03-31$37.12M
10-Q · filed 2024-05-08
$74.43M
derived: sum of 2 quarters · filed 2025-03-07
$108.65M
derived: sum of 3 quarters · filed 2025-03-07
$142.73M
derived: sum of 4 quarters · filed 2025-03-07
2022-12-31$37.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
$71.53M
derived: sum of 2 quarters · filed 2025-03-07
$105.62M
derived: sum of 3 quarters · filed 2025-03-07
$135.78M
10-K · filed 2025-03-07
2022-09-30$34.22M
10-Q · filed 2023-11-09
$68.31M
derived: sum of 2 quarters · filed 2023-11-09
$98.47M
10-Q · filed 2023-11-09
$129.94M
derived: sum of 4 quarters · filed 2024-03-13
2022-06-30$34.09M
10-Q · filed 2023-08-09
$64.25M
10-Q · filed 2023-08-09
$95.72M
derived: sum of 3 quarters · filed 2024-03-13
$123.81M
derived: sum of 4 quarters · filed 2024-03-13
2022-03-31$30.16M
10-Q · filed 2023-05-04
$61.64M
derived: sum of 2 quarters · filed 2024-03-13
$89.72M
derived: sum of 3 quarters · filed 2024-03-13
$118.88M
derived: sum of 4 quarters · filed 2024-03-13
2021-12-31$31.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13
$59.56M
derived: sum of 2 quarters · filed 2024-03-13
$88.72M
derived: sum of 3 quarters · filed 2024-03-13
$114.41M
10-K · filed 2024-03-13
2021-09-30$28.09M
10-Q · filed 2022-11-04
$57.24M
derived: sum of 2 quarters · filed 2022-11-04
$82.93M
10-Q · filed 2022-11-04
$112.67M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$29.15M
10-Q · filed 2022-08-04
$54.84M
10-Q · filed 2022-08-04
$84.58M
derived: sum of 3 quarters · filed 2023-02-28
$101.37M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$25.69M
10-Q · filed 2022-05-05
$55.43M
derived: sum of 2 quarters · filed 2023-02-28
$72.22M
derived: sum of 3 quarters · filed 2023-02-28
$83.19M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$29.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$46.53M
derived: sum of 2 quarters · filed 2023-02-28
$57.50M
derived: sum of 3 quarters · filed 2023-02-28
$66.34M
10-K · filed 2023-02-28
2020-09-30$16.79M
10-Q · filed 2021-11-04
$16.79M
10-Q · filed 2020-11-06
$27.76M
derived: sum of 2 quarters · filed 2021-11-04
$36.60M
10-Q · filed 2021-11-04
$36.60M
10-Q · filed 2020-11-06
$42.42M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$10.97M
10-Q · filed 2021-08-06
$10.97M
10-Q · filed 2020-08-10
$19.82M
10-Q · filed 2021-08-06
$19.82M
10-Q · filed 2020-08-10
$25.63M
derived: sum of 3 quarters · filed 2022-02-28
$42.61M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$8.84M
10-Q · filed 2021-05-06
$8.84M
10-Q · filed 2020-05-08
$14.65M
derived: sum of 2 quarters · filed 2022-02-28
$31.63M
derived: sum of 3 quarters · filed 2022-02-28
$38.28M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$5.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$22.79M
derived: sum of 2 quarters · filed 2022-02-28
$29.43M
derived: sum of 3 quarters · filed 2022-02-28
$35.03M
10-K · filed 2022-02-28
$35.03M
10-K · filed 2020-03-10
2019-09-30$16.98M
10-Q · filed 2020-11-06
$23.62M
derived: sum of 2 quarters · filed 2020-11-06
$29.22M
10-Q · filed 2020-11-06
$34.25M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$6.64M
10-Q · filed 2020-08-10
$12.24M
10-Q · filed 2020-08-10
$17.27M
derived: sum of 3 quarters · filed 2020-08-10
$22.17M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$5.59M
10-Q · filed 2020-05-08
$10.63M
derived: sum of 2 quarters · filed 2020-05-08
$15.53M
derived: sum of 3 quarters · filed 2020-05-08
$20.50M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$5.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$9.93M
derived: sum of 2 quarters · filed 2020-03-10
$14.90M
derived: sum of 3 quarters · filed 2020-03-10
$18.88M
10-K · filed 2020-03-10
2018-09-30$4.90M
10-Q · filed 2019-11-12
$9.87M
derived: sum of 2 quarters · filed 2019-11-12
$13.85M
10-Q · filed 2019-11-12
$17.83M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$4.97M
10-Q · filed 2019-08-09
$8.95M
10-Q · filed 2019-08-09
$12.94M
derived: sum of 3 quarters · filed 2019-08-09
$16.53M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$3.98M
10-Q · filed 2019-05-09
$7.97M
derived: sum of 2 quarters · filed 2019-05-09
$11.56M
derived: sum of 3 quarters · filed 2019-05-09
$14.82M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$3.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$7.58M
derived: sum of 2 quarters · filed 2019-03-13
$10.84M
derived: sum of 3 quarters · filed 2019-03-13
$13.86M
10-K · filed 2019-03-13
2017-09-30$3.59M
10-Q · filed 2018-11-08
$6.85M
derived: sum of 2 quarters · filed 2018-11-08
$9.87M
10-Q · filed 2018-11-08
$12.82M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$3.26M
10-Q · filed 2018-08-09
$6.28M
10-Q · filed 2018-08-09
$9.22M
derived: sum of 3 quarters · filed 2018-08-09
$12.18M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$3.02M
10-Q · filed 2018-05-03
$5.97M
derived: sum of 2 quarters · filed 2018-05-03
$8.92M
derived: sum of 3 quarters · filed 2018-05-03
$11.68M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$2.94M
derived: 10-K 9 month − 10-Q 6 month · filed 2018-03-08
$5.90M
derived: sum of 2 quarters · filed 2018-03-08
$8.66M
10-K · filed 2018-03-08
$11.87M
10-K · filed 2018-03-08
2016-09-30$2.96M
10-Q · filed 2017-11-02
$5.72M
10-Q · filed 2016-11-14
$8.92M
10-Q · filed 2017-11-02
$11.99M
derived: sum of 4 quarters · filed 2017-11-02
2016-06-30$2.76M
10-Q · filed 2017-08-09
$5.97M
10-Q · filed 2017-08-09
$9.03M
derived: sum of 3 quarters · filed 2017-08-09
$11.29M
derived: sum of 4 quarters · filed 2017-08-09
2016-03-31$3.21M
10-Q · filed 2017-05-04
$6.27M
derived: sum of 2 quarters · filed 2017-05-04
$8.53M
derived: sum of 3 quarters · filed 2017-05-04
$10.63M
10-KT · filed 2017-03-13
2015-12-31$3.06M
10-Q · filed 2016-02-11
$5.32M
derived: sum of 2 quarters · filed 2016-11-14
$7.43M
10-KT · filed 2017-03-13
$9.49M
derived: sum of 4 quarters · filed 2016-11-14
2015-09-30$2.26M
10-Q · filed 2016-11-14
$4.36M
10-Q · filed 2016-11-14
$6.43M
derived: sum of 3 quarters · filed 2016-11-14
$8.02M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$2.10M
10-Q · filed 2016-08-15
$4.17M
derived: sum of 2 quarters · filed 2016-08-15
$5.76M
derived: sum of 3 quarters · filed 2016-08-15
$7.36M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$2.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28
$3.65M
derived: sum of 2 quarters · filed 2016-06-28
$5.25M
derived: sum of 3 quarters · filed 2016-06-28
$6.76M
10-K · filed 2016-06-28
2014-12-31$1.59M
10-Q · filed 2016-02-11
$3.19M
derived: sum of 2 quarters · filed 2016-02-11
$4.70M
10-Q · filed 2016-02-11
$6.12M
derived: sum of 4 quarters · filed 2016-02-11
2014-09-30$1.60M
10-Q · filed 2015-11-16
$3.11M
10-Q · filed 2015-11-16
$4.52M
derived: sum of 3 quarters · filed 2015-11-16
$5.95M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$1.51M
10-Q · filed 2015-08-06
$2.92M
derived: sum of 2 quarters · filed 2015-08-06
$4.35M
derived: sum of 3 quarters · filed 2015-08-06
$5.71M
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19
$2.84M
derived: sum of 2 quarters · filed 2015-05-19
$4.20M
derived: sum of 3 quarters · filed 2015-05-19
$5.52M
10-K · filed 2015-05-19
2013-12-31$1.42M
10-Q · filed 2015-02-05
$2.78M
derived: sum of 2 quarters · filed 2015-02-05
$4.10M
10-Q · filed 2015-02-05
$4.10M
derived: sum of 4 quarters · filed 2015-02-05
2013-09-30$1.36M
10-Q · filed 2014-11-12
$2.67M
10-Q · filed 2014-11-12
$2.68M
derived: sum of 3 quarters · filed 2014-11-12
$4.16M
derived: sum of 4 quarters · filed 2014-11-12
2013-06-30$1.31M
10-Q · filed 2014-07-31
$1.32M
derived: sum of 2 quarters · filed 2014-07-31
$2.80M
derived: sum of 3 quarters · filed 2014-07-31
$4.25M
derived: sum of 4 quarters · filed 2014-07-31
2013-03-31$1.53K
10-K · filed 2013-06-25
$1.49M
derived: sum of 2 quarters · filed 2014-02-13
$2.93M
derived: sum of 3 quarters · filed 2014-02-13
$5.84M
10-K · filed 2014-06-25
2012-12-31$1.49M
10-Q · filed 2014-02-13
$2.93M
derived: sum of 2 quarters · filed 2014-02-13
$4.31M
10-Q · filed 2014-02-13
$4.31M
derived: sum of 4 quarters · filed 2014-02-13
2012-09-30$1.44M
10-Q · filed 2013-11-18
$2.82M
10-Q · filed 2013-11-18
$2.82M
derived: sum of 3 quarters · filed 2013-11-18
$2.82M
derived: sum of 4 quarters · filed 2013-11-18
2012-06-30$1.38M
10-Q · filed 2013-08-14
$1.38M
derived: sum of 2 quarters · filed 2013-08-14
$1.38M
derived: sum of 3 quarters · filed 2013-08-14
$1.38M
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$1.32K
10-K · filed 2013-06-25
$3.18K
derived: sum of 2 quarters · filed 2013-06-25
$4.87K
derived: sum of 3 quarters · filed 2013-06-25
$6.60M
10-K · filed 2013-06-25
2011-12-31$1.86K
10-K · filed 2013-06-25
$1.86M
10-Q · filed 2012-02-21
$3.55K
derived: sum of 2 quarters · filed 2013-06-25
$5.28M
10-Q · filed 2013-02-14
$1.29M
derived: sum of 4 quarters · filed 2013-06-25
2011-09-30$1.69K
10-K · filed 2013-06-25
$1.69M
10-Q · filed 2011-11-14
$3.42M
10-Q · filed 2012-11-09
$1.29M
derived: sum of 3 quarters · filed 2013-06-25
$2.48M
derived: sum of 4 quarters · filed 2013-06-25
2011-06-30$1.73K
10-K · filed 2013-06-25
$1.73M
10-Q · filed 2011-08-15
$1.29M
derived: sum of 2 quarters · filed 2013-06-25
$2.48M
derived: sum of 3 quarters · filed 2013-06-25
$3.71M
derived: sum of 4 quarters · filed 2013-06-25
2011-03-31$1.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27
$2.48M
derived: sum of 2 quarters · filed 2012-06-27
$3.70M
derived: sum of 3 quarters · filed 2012-06-27
$4.77M
10-K · filed 2012-06-27
2010-12-31$1.19M
10-Q · filed 2012-02-21
$2.41M
derived: sum of 2 quarters · filed 2012-02-21
$3.48M
10-Q · filed 2012-02-21
2010-09-30$1.23M
10-Q · filed 2011-11-14
$2.29M
10-Q · filed 2011-11-14
2010-06-30$1.07M
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Apnimed, Inc. (APMD)United States$0.899B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71